Hartel Jennifer Christina, Merz Nadine, Grösch Sabine
Institute of Clinical Pharmacology, Goethe-University Frankfurt. Frankfurt am Main, Frankfurt, Germany.
Department of Life Sciences, Goethe-University Frankfurt, Frankfurt, Germany.
Front Pharmacol. 2022 Sep 13;13:1002915. doi: 10.3389/fphar.2022.1002915. eCollection 2022.
The concept of proper resolution of inflammation rather than counteracting it, gained a lot of attention in the past few years. Re-assembly of tissue and cell homeostasis as well as establishment of adaptive immunity after inflammatory processes are the key events of resolution. Neutrophiles and macrophages are well described as promotors of resolution, but the role of T cells is poorly reviewed. It is also broadly known that sphingolipids and their imbalance influence membrane fluidity and cell signalling pathways resulting in inflammation associated diseases like inflammatory bowel disease (IBD), atherosclerosis or diabetes. In this review we highlight the role of sphingolipids in T cells in the context of resolution of inflammation to create an insight into new possible therapeutical approaches.
在过去几年中,炎症的适度消退而非对抗的概念受到了广泛关注。组织和细胞内环境稳定的重新建立以及炎症过程后适应性免疫的形成是炎症消退的关键事件。嗜中性粒细胞和巨噬细胞作为炎症消退的促进因子已广为人知,但T细胞的作用却鲜有综述。人们也普遍知道,鞘脂及其失衡会影响膜流动性和细胞信号通路,从而导致炎症相关疾病,如炎症性肠病(IBD)、动脉粥样硬化或糖尿病。在本综述中,我们着重探讨鞘脂在T细胞中在炎症消退背景下的作用,以期深入了解新的潜在治疗方法。